Prosecution Insights
Last updated: May 29, 2026

Shanghai Seme Cell Technology Co. Ltd.

4 pending office actions • 2 art units • 2 examiners • 0 of 4 (0%) have an AI response strategy ready

Portfolio Summary

4
Total Pending OAs
1
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
2
Medium (50%)
0
Easy (0%)
2
Unknown (50%)

Rejection Statute Mix

BucketCases
§103 only1 (25%)
§102 only1 (25%)
No statute on record2 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BOECKELMAN, JACOB A 2 36.1% +46.3%
UNDERDAHL, THANE E 2 59.0% +50.0%

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
17635524 FAT EXTRACT WITHOUT ADDED INGREDIENTS, PREPARATION METHOD THEREFOR AND USE THEREOF FOR GENERATING DROPLET ARRAY ON MICROFLUIDIC CHIP BOECKELMAN, JACOB A 25d overdue
18039639 THERAPEUTIC USE OF CELL-FREE FAT EXTRACT FOR OSTEOPOROSIS BOECKELMAN, JACOB A 24d overdue
18252254 THERAPEUTIC APPLICATION OF CELL-FREE FAT EXTRACT TO ARTHRITIS UNDERDAHL, THANE E 14d
18040466 Therapeutic Use of Cell-free Fat Extract Solution for Pulmonary Diseases UNDERDAHL, THANE E 16d

Top Art Units

Art UnitApps
1655 2
1699 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18039639 THERAPEUTIC USE OF CELL-FREE FAT EXTRACT FOR OSTEOPOROSIS BOECKELMAN, JACOB A 1655 Other Final Rejection 24d overdue Pending May 31, 2023
18252254 THERAPEUTIC APPLICATION OF CELL-FREE FAT EXTRACT TO ARTHRITIS UNDERDAHL, THANE E 1699 §102 Non-Final OA 14d Pending May 09, 2023
18040466 Therapeutic Use of Cell-free Fat Extract Solution for Pulmonary Diseases UNDERDAHL, THANE E 1699 §103 Final Rejection 16d Pending Feb 03, 2023
17635524 FAT EXTRACT WITHOUT ADDED INGREDIENTS, PREPARATION METHOD THEREFOR AND USE THEREOF FOR GENERATING DROPLET ARRAY ON MICROFLUIDIC CHIP BOECKELMAN, JACOB A 1655 Other Final Rejection 25d overdue Pending Feb 15, 2022

Managing Shanghai Seme Cell Technology Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month